According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit
Wegener's Granulomatosis, which is considered to be an autoimmune disease.
[LDN_Autoimmune] presents a case report of one patient with
Wegener's Granulomatosis who experienced significant improvement in symptoms
(decrease in congestion and a return to baseline energy levels) and ANCA titers.
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of Wegener's Granulomatosis
with LDN.
Please see What is Low Dose Naltrexone?
for more information.
[McCulley2018, pp 28, 62] reports that Wegener's granulomatosis is a systemic
autoimmune disorder, and proposes an approach to treating this disease, which should be
supervised by a properly trained medical professional.
Dr. Weyrich has considerable interest in this topic, but has
not treated any cases of Wegener's Granulomatosis
with Immune System Balancing.
Please see What is Immune System Balancing?
for more information.